A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer
• Treatments: Anidulafungin; Echinocandins; Voriconazole

Criteria

Inclusion Criteria:

• Healthy adult subjects willing to comply with the study requirement.

Exclusion Criteria:

• Clinical significant disease.

• Sensitive to study medication.

• Not willing to comply with the study requirement.